Burning Rock Biotech Limited
BNR
$4.52
-$0.18-3.83%
| 09/30/2024 | 03/31/2024 | 12/31/2023 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | 37.19% | 36.30% | 36.30% | 34.79% |
| Total Depreciation and Amortization | -- | 7.14% | 7.14% | 7.14% | 143.54% |
| Total Amortization of Deferred Charges | -- | -42.75% | -42.75% | -42.75% | -4.71% |
| Total Other Non-Cash Items | -- | -13.95% | -26.46% | -26.46% | -49.02% |
| Change in Net Operating Assets | -- | -359.99% | -359.99% | -359.99% | 83.91% |
| Cash from Operations | -- | 58.86% | 46.64% | 46.64% | 42.71% |
| Capital Expenditure | -- | 88.65% | 88.65% | 88.65% | 70.02% |
| Sale of Property, Plant, and Equipment | -- | -96.59% | -96.59% | -96.59% | 284.28% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -99.59% | -102.59% | -102.59% | -65.78% |
| Cash from Investing | -- | -363.02% | -26.78% | -26.78% | 81.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 94.71% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 90.29% | 90.29% | 90.29% | -1,582.30% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -414.24% | -247.78% | -247.78% | 150.80% |
| Cash from Financing | -- | 45.37% | 47.93% | 47.93% | 37.30% |
| Foreign Exchange rate Adjustments | -- | -75.65% | -89.92% | -89.92% | -93.02% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 53.39% | 42.78% | 42.78% | 45.03% |
